NCT01548066View on ClinicalTrials.gov

The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Androgenetic AlopeciaMale Pattern Baldness
Interventions
DRUG

Valproic Acid

spray 7.2% of sodium valproate on scalp twice a day (morning and evening) for 24 weeks

DRUG

Control placebo

spray vehicle without sodium valproate on scalp twice a day (morning and evening) for 24 weeks

Trial Locations (1)

110-744

Department of Dermatology, Seoul National University Hospital, Seoul

All Listed Sponsors
collaborator

Amorepacific Corporation

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT01548066 - The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss | Biotech Hunter | Biotech Hunter